Skip to main content
Mobile dropdown close
More coming soon
China: Explore these additional resources
1 - 10 of 16 Displaying Results
What Role Does a 3PL Play in Global Markets?
3PLs provide an essential service for pharma brand owners, not just in the U.S. and EU, but in other markets such as Korea, China and Brazil. Find…
2019 Regulatory Update: China
Learn about China's new drug administration law and serialization framework for both medicines and vaccines from TraceLink’s Brian Daleiden.
Are Your Products China Ready? Three Key Decisions for Multinational Pharma Companies
China's drug administration law and serialization framework for medicines could affect your China product packaging strategy. Learn how today.
Must-Know China Track and Trace Compliance Terms for the Pharmaceutical Supply Chain
The 2019 China Drug Administration Law introduced track and trace terms and agencies that you need to understand for your China compliance strategy.
China's Technical Requirements and Compliance Deadlines: What You Need to Know Now
Watch this on-demand webinar to get expert guidance on China’s directives so you can begin to include in your global serialization and compliance…
China eCode or GS1 Encoding? Weighing the Benefits and Risks
China eCode or GS1 Encoding: Which one is right for you? Watch this short webinar excerpt to understand key considerations for your China product…
China Reporting and Compliance Systems: Key Considerations
What makes China compliance so challenging? Watch this brief overview of China’s 3-tier reporting system to help guide your China serialization…
China Compliance: Systems and Standards at a Glance
This infographic provides an overview of the key requirements of China’s track and trace law so you can begin your serialization and compliance…
Will China Roll Out More Intermediate Deadlines Before 2022?
Learn how TraceLink helps companies prepare for new deadlines as China’s NMPA implements its revamped traceability system.
Will My Current China Reports Work with the New Traceability Systems?
Learn how China’s amended Drug Administration Law expands the scope of NMPA reporting requirements and impacts your company’s serialization strategy.